Repository logo
 
Publication

Securing wider EU commitment to the elimination of hepatitis C virus

dc.contributor.authorWedemeyer, Heiner
dc.contributor.authorTergast, Tammo L.
dc.contributor.authorLazarus, Jeffrey V.
dc.contributor.authorRazavi, Homie
dc.contributor.authorBakoyannis, Kostas
dc.contributor.authorBaptista-Leite, Ricardo
dc.contributor.authorBartoli, Marco
dc.contributor.authorBruggmann, Philip
dc.contributor.authorBuşoi, Cristian Silviu
dc.contributor.authorButi, Maria
dc.contributor.authorCarballo, Manuel
dc.contributor.authorCastera, Laurent
dc.contributor.authorColombo, Massimo
dc.contributor.authorCoutinho, Rodrigo Sousa
dc.contributor.authorDadon, Yuval
dc.contributor.authorEsmat, Gamal
dc.contributor.authorEsteban, Rafael
dc.contributor.authorFarran, Joan Colom
dc.contributor.authorGillyon-Powell, Mark
dc.contributor.authorGoldberg, David
dc.contributor.authorHutchinson, Sharon
dc.contributor.authorJanssen, Harry L.A.
dc.contributor.authorKalamitsis, George
dc.contributor.authorKondili, Loreta A.
dc.contributor.authorLambert, John S.
dc.contributor.authorMarinho, Rui Tato
dc.contributor.authorMaticic, Mojca
dc.contributor.authorPatricello, Aldo
dc.contributor.authorPeck-Radosavljevic, Markus
dc.contributor.authorPol, Stanislas
dc.contributor.authorPoljak, Mario
dc.contributor.authorPop, Cora
dc.contributor.authorSokol, Tomislov
dc.contributor.authorSypsa, Vana
dc.contributor.authorTözün, Nurdan
dc.contributor.authorYounossi, Zobair
dc.contributor.authorAghemo, Alessio
dc.contributor.authorPapatheodoridis, George V.
dc.contributor.authorHatzakis, Angelos
dc.date.accessioned2023-02-15T11:27:49Z
dc.date.available2023-02-15T11:27:49Z
dc.date.issued2023-02
dc.description.abstractIn 2016, the Hepatitis B and C Public Policy Association (HepBCPPA), gathered all the main stakeholders in the field of hepatitis C virus (HCV) to launch the now landmark HCV Elimination Manifesto, calling for the elimination of HCV in the EU by 2030. Since then, many European countries have made progress towards HCV elimination. Multiple programmes—from the municipality level to the EU level—were launched, resulting in an overall decrease in viremic HCV infections and liver-related mortality. However, as of 2021, most countries are not on track to reach the 2030 HCV elimination targets set by the WHO. Moreover, the COVID-19 pandemic has resulted in a decrease in HCV diagnoses and fewer direct-acting antiviral treatment initiations in 2020. Diagnostic and therapeutic tools to easily diagnose and treat chronic HCV infection are now well established. Treating all patients with chronic HCV infection is more cost-saving than treating and caring for patients with liver-related complications, decompensated cirrhosis or hepatocellular carcinoma. It is more important than ever to reinforce and scale-up action towards HCV elimination. Yet, efforts urgently need the dedicated commitment of policymakers at all governmental and policy levels. Therefore, the third EU Policy Summit, held in March 2021, featured EU parliamentarians and other key decision makers to promote dialogue and take strides towards securing wider EU commitment to advance and achieve HCV elimination by 2030. We have summarized the key action points and reported the ‘Call-to-Action’ statement supported by all the major relevant European associations in the field.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.1111/liv.15446pt_PT
dc.identifier.eid85144100419
dc.identifier.issn1478-3223
dc.identifier.pmid36196744
dc.identifier.urihttp://hdl.handle.net/10400.14/40228
dc.identifier.wos000920663500004
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt_PT
dc.subjectEpidemiologypt_PT
dc.subjectHealth policypt_PT
dc.subjectHepatitispt_PT
dc.subjectHepatitis Cpt_PT
dc.subjectPreventionpt_PT
dc.titleSecuring wider EU commitment to the elimination of hepatitis C viruspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage291pt_PT
oaire.citation.issue2pt_PT
oaire.citation.startPage276pt_PT
oaire.citation.titleLiver Internationalpt_PT
oaire.citation.volume43pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
535345.pdf
Size:
1.22 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.44 KB
Format:
Item-specific license agreed upon to submission
Description: